Serious adverse cutaneous and hepatic toxicities associated with nevirapine use by non-HIV-infected individuals.

Abstract

BACKGROUND Nevirapine is a nonnucleoside reverse transcriptase antiretroviral agent. Among HIV-infected individuals, rare instances (<1%) of serious cutaneous and hepatic toxicity have been reported. Because of its favorable pharmacokinetic profile, non-HIV-infected individuals have received nevirapine-containing postexposure prophylaxis (PEP). OBJECTIVE… (More)

Topics

Cite this paper

@article{Patel2004SeriousAC, title={Serious adverse cutaneous and hepatic toxicities associated with nevirapine use by non-HIV-infected individuals.}, author={Shilpa Majmudar Patel and Stuart K Johnson and Steven M. Belknap and Juliana C. N. Chan and Beverly E. Sha and Charles L. Bennett}, journal={Journal of acquired immune deficiency syndromes}, year={2004}, volume={35 2}, pages={120-5} }